SUMITOMO CHEMCL Total Liabilities 2016-2023 | SOMMY
SUMITOMO CHEMCL total liabilities from 2016 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
SUMITOMO CHEMCL Annual Total Liabilities
(Millions of US $) |
| 2023 |
$19,805 |
| 2022 |
$21,294 |
| 2021 |
$22,655 |
| 2020 |
$20,780 |
| 2019 |
$16,395 |
| 2018 |
$17,098 |
| 2017 |
$15,149 |
| 2016 |
$13,945 |
| 2015 |
$ |
SUMITOMO CHEMCL Quarterly Total Liabilities
(Millions of US $) |
| 2023-06-30 |
$20,614 |
| 2022-06-30 |
$21,611 |
| 2022-03-31 |
$21,294 |
| 2021-12-31 |
|
| 2021-09-30 |
|
| 2021-06-30 |
|
| 2021-03-31 |
$22,655 |
| 2020-12-31 |
|
| 2020-09-30 |
|
| 2020-06-30 |
|
| 2020-03-31 |
$20,780 |
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
$16,395 |
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
$17,098 |
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
$15,149 |
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
$13,945 |
| 2015-12-31 |
|
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Diversified |
$3.752B |
$20.469B |
|
Sumitomo Chemical Co., Ltd. engages in the manufacture and sale of chemicals. Its operating segments consists of Basic Chemicals, Petrochemicals and Plastics, Information Technology related Chemicals, Health and Crop Sciences, Pharmaceuticals and Others. Basic Chemicals segment produces organic and inorganic chemicals, synthetic fiber raw materials, methyl methacrylate products, alumina products, additives and dyestuffs. Petrochemicals and Plastics segment consists of synthetic resin, rubber and other resin processed products. IT-Related Chemicals segment sells optical products, color filters, semiconductor processing materials, compound semiconductor materials and battery components. Health and Crop Sciences segment distributes fertilizers, pesticides, insecticides, tropical infectious disease control materials and feed additives. Pharmaceuticals segment develops and sells ethical pharmaceuticals, radiopharmaceutical and radiation therapy equipment. Others segment provides supply of electrical power and stea
|
